Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
929.20
-17.90 (-1.89%)
< Home < Back

Zydus Lifesciences recalls 1,116 boxes of Fulvestrant Injection in US market

Date: 05-09-2022

Zydus Lifesciences is recalling products in the US, the world's largest market for medicines, due to manufacturing issues. As per the Enforcement Report by US Food and Drug Administration (USFDA), the company is recalling 1,116 boxes of Fulvestrant Injection, a drug used to treat breast cancer.

According to the USFDA, the company's US-based unit is recalling the affected lot due to Failed Impurities/Degradation Specifications. The affected lot has been manufactured in India and has been distributed in the US by New Jersey-based Zydus Pharmaceuticals (USA). Zydus initiated the Class II voluntary recall on July 15 this year.

Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.